Studies and Evidence

Exceptionally cost-efficient system requiring no recalibration, maintenance, or sensor exchange during the entire lifetime (up to 5000 measurement trials) due to high-precision Bosch technology made in Germany.

• Ergonomics similar to playing a flute: Patient exhales against light pressure through the mouthpiece into the handheld.
• Two measurement modes: 10 seconds for adults and 6 seconds for children (7-11 years).
• Two visualizations available to guide the user quickly and intuitively through the measurement maneuver.
• FeNO values available right after the measurement.
• If first attempt fails, Vivatmo pro is ready to measure again within 10 seconds.
• Winner of the Red Dot Design Award.

• Remote software updates available via Vivasuite connectivity solution.
• Common interfaces and data exchange standards enable seamless IT integration: Wifi, USB, Ethernet, HL7, and GDT.
• Patient data management system of up to 10,000 patient files, including export function and immediate printing.
• Backups and optional user login to support data security in clinical environment.
• Portable handheld can perform stand-alone measurements when not paired to basestation. Data is subsequently transmitted via Bluetooth.

• Reduced infection risk due to easy cleaning, no inhalation through device, and highly efficient germ filter in disposable mouthpiece.
• Cleaning with alcohol disinfectant wipes (max. 30%).
• Bacterial filtration efficiency (BFE): 99.998%.
• Viral filtration efficiency (VFE): 99.960%.

The entire Vivatmo system is climate-neutral through carbon offsets.

The integration of Fractional exhaled nitric oxide (FeNO) measurement into clinical practice is supported by a robust body of scientific evidence. Numerous studies have demonstrated its value in improving diagnostic accuracy and optimizing treatment strategies. Below is a summary of the key clinical benefits for which there is strong evidence